Issue 4/2017
Content (11 Articles)
B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (D Persky, Section Editor)
Therapeutic Options for Aggressive T-Cell Lymphomas
Jennifer K. Lue, Anna Kress, Jennifer E. Amengual
B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (D Persky, Section Editor)
An Update on the Use of Immunotherapy in the Treatment of Lymphoma
Thomas U. Marron, Matko Kalac, Joshua Brody
Health Economics (N Khera, Section Editor)
Patterns of Care and Survival for Elderly Acute Myeloid Leukemia—Challenges and Opportunities
Abhishek A. Mangaonkar, Mrinal M. Patnaik
Health Economics (N Khera, Section Editor)
Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve?
Thomas W. LeBlanc, Eric J. Roeland, Areej El-Jawahri
Health Economics (N Khera, Section Editor)
Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?
Sikander Ailawadhi, Kirtipal Bhatia, Sonikpreet Aulakh, Zahara Meghji, Asher Chanan-Khan
Health Economics (N Khera, Section Editor)
Coordination of Care in Survivorship After Treatment of Hematological Malignancies—The Journey is Not Over Yet
Catherine J. Lee, Lori S. Muffly
Health Economics (N Khera, Section Editor)
Patient and Caregiver Adjustment to Hematopoietic Stem Cell Transplantation: a Systematic Review of Dyad-Based Studies
Shelby Langer, Christine Lehane, Jean Yi
CART and Immunotherapy (M Ruella, Section Editor)
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy
Andrew D. Fesnak, Patrick J. Hanley, Bruce L. Levine
CART and Immunotherapy (M Ruella, Section Editor)
Novel Immunotherapies for Multiple Myeloma
Mattia D’Agostino, Mario Boccadoro, Eric L. Smith
CART and Immunotherapy (M Ruella, Section Editor)
Targeting Immune System Alterations in Hodgkin Lymphoma
Natalie S. Grover, Barbara Savoldo
Acute Lymphocytic Leukemias (K Ballen, Section Editor)
Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice
Marlise R. Luskin, Daniel J. DeAngelo